NCT01397955View on ClinicalTrials.gov

Julina Post-marketing Surveillance for Postmenopausal Osteoporosis in Japan

CompletedOBSERVATIONAL

Enrollment

148

Participants

Timeline

Start Date

January 31, 2009

Primary Completion Date

January 31, 2014

Study Completion Date

April 30, 2014

Conditions

Osteoporosis, Postmenopausal

Interventions

DRUG

E2 transdermal (Julina, BAY86-5435)

Patients in daily life treatment receiving Julina for postmenopausal osteoporosis

Trial Locations (1)

Unknown

Many Locations

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Bayer

INDUSTRY